chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: nausea; headache; fatigue; muscle pain; Dizzy; all over achiness; This is a spontaneous report from a contactable other HCP (patient). A 27-years-old non pregnant female patient received bnt162b2 (COMIRNATY, solution for injection, Lot Number: EL9284), via an unspecified route of administration, administered in Arm Left on 13Feb2021 13:15 (at the age of 27-years-old) as dose 2, single for COVID-19 immunisation. Medical history included Hay fever, migraines with aura, PCOS, acne vulgaris, back spasms from an unknown date and unknown if ongoing. The patient was allergic to Dust, mold, ragweed, pollens, horses, rabbits, hamsters. The patient's concomitant medications included Montelukast, cetirizine, flonase, metoprolol all drugs received within 2 weeks of vaccination. The patient previously received bnt162b2 (COMIRNATY, solution for injection, Lot Number: EL8982), via an unspecified route of administration, administered in Arm Left on :23Jan2021 13:15 (at the age of 27-years-old) as dose 1, single for COVID-19 immunisation. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not having COVID prior vaccination and has not been COVID tested post vaccination. On 13Feb2021 15:00, the patient had Dizzy, all over achiness, nausea, headache, fatigue, muscle pain. The patient did not receive any treatment for the events. The outcome of the events was not recovering.  Follow-up attempts completed. No further information expected.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: nausea; headache; fatigue; muscle pain; Dizzy; all over achiness; This is a spontaneous report from a contactable other HCP (patient). A 27-years-old non pregnant female patient received bnt162b2 (COMIRNATY, solution for injection, Lot Number: EL9284), via an unspecified route of administration, administered in Arm Left on 13Feb2021 13:15 (at the age of 27-years-old) as dose 2, single for COVID-19 immunisation. Medical history included Hay fever, migraines with aura, PCOS, acne vulgaris, back spasms from an unknown date and unknown if ongoing. The patient was allergic to Dust, mold, ragweed, pollens, horses, rabbits, hamsters. The patient's concomitant medications included Montelukast, cetirizine, flonase, metoprolol all drugs received within 2 weeks of vaccination. The patient previously received bnt162b2 (COMIRNATY, solution for injection, Lot Number: EL8982), via an unspecified route of administration, administered in Arm Left on :23Jan2021 13:15 (at the age of 27-years-old) as dose 1, single for COVID-19 immunisation. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not having COVID prior vaccination and has not been COVID tested post vaccination. On 13Feb2021 15:00, the patient had Dizzy, all over achiness, nausea, headache, fatigue, muscle pain. The patient did not receive any treatment for the events. The outcome of the events was not recovering.  Follow-up attempts completed. No further information expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hypersomnia
Clinical narrative: Extremely Tired; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 69-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6201, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 12Feb2021 (age at vaccination was 69 years) as dose 1, single for COVID-19 immunization. The patient's medical history included known allergies from an unknown date. The patient's concomitant medications were not reported. The facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 12Feb2021, the patient was extremely tired. No treatment was received for the adverse event. The outcome of the event was resolved on an unspecified date in 2021.   Follow-up attempts completed. No further information expected.
Age: 69.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue
Clinical narrative: Extremely Tired; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 69-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6201, Expiration date: unknown) via an unspecified route of administration, administered in left arm on 12Feb2021 (age at vaccination was 69 years) as dose 1, single for COVID-19 immunization. The patient's medical history included known allergies from an unknown date. The patient's concomitant medications were not reported. The facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 12Feb2021, the patient was extremely tired. No treatment was received for the adverse event. The outcome of the event was resolved on an unspecified date in 2021.   Follow-up attempts completed. No further information expected.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness within 2 hours after getting Covid  injection. It's been 4 days since getting my shot and  I still am having the dizziness.; This is a spontaneous report from a contactable consumer or other non hcp (patient reported for herself). A 73-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Left on 12Feb2021 10:30 pm (Batch/Lot Number: EN6201) as dose 1, single for covid-19 immunization (at the age of 73-years-old). Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing. There were no concomitant medications. Patient had not received any other vaccine in four weeks and had not received other medications in two weeks of vaccination. Patient had no covid prior vaccination and had not been tested for covid post vaccination. Patient had no known allergies. Facility type vaccine was reported as other. It was reported that on 12Feb2021 at 12:00 pm patient had dizziness within 2 hours after getting covid injection. It's been 4 days since getting her shot and she was still am having the dizziness. Patient had not received any treatment for the event. Patient was not recovered from the event.   Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Injection site pain, Nausea, Vestibular migraine
Clinical narrative: sore arm; Vestibular headache; nausea; real unsteady on her feet; Vertigo; Upset stomach; Do not feel so well; This is a spontaneous report from a contactable consumer (Patient).  A 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via an unspecified route of administration on an unspecified date in 2021 as dose1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced sore arm, vestibular headache, nausea, real unsteady on her feet, vertigo, upset stomach, do not feel so well. It was reported that patient after first dose on last Wednesday (in 2021) had She reported that beside a "minor sore arm", she "felt fine" on Thursday and Friday. She added she "didn't move off the couch" on Saturday because she had a "vestibular headache and nausea". She specified she was able to "move some" on Sunday but "wouldn't pick up" things on the floor, and felt "real unsteady on her feet". She mentioned she still has her symptoms today and feels "fairly miserable".  She explained she is "prone to vertigo" because she has "benign positional vertigo". She asked if this experience was normal to the first dose of the vaccine and if the vaccine emphasizing her condition, the positional vertigo. Consumer stated that she should go on to the portal but to tell the truth she had such bad vertigo. She do not use very much and certainly not sit in the computer.  She was fine on Thursday and Friday and Saturday morning she have the worse, severe headache she have ever had, unbelievable vertigo and she have got an upset stomach. So basically, importantly it says that she have just had (incomplete sentence). Her immune system is 'driving' up to the vaccine but she certainly going to get the second shot because COVID gives her more than what she was going (Clarification unknown) through but is this a normal reaction. In response to further probing, consumer stated, she do not feel so well. She do not want to spend another 8 or 10 minutes in answering questions. Events were assessed as non-serious by reporter. Outcome of all events was unknown.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Gait disturbance, Headache, Malaise, Nausea
Clinical narrative: sore arm; Vestibular headache; nausea; real unsteady on her feet; Vertigo; Upset stomach; Do not feel so well; This is a spontaneous report from a contactable consumer (Patient).  A 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via an unspecified route of administration on an unspecified date in 2021 as dose1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced sore arm, vestibular headache, nausea, real unsteady on her feet, vertigo, upset stomach, do not feel so well. It was reported that patient after first dose on last Wednesday (in 2021) had She reported that beside a "minor sore arm", she "felt fine" on Thursday and Friday. She added she "didn't move off the couch" on Saturday because she had a "vestibular headache and nausea". She specified she was able to "move some" on Sunday but "wouldn't pick up" things on the floor, and felt "real unsteady on her feet". She mentioned she still has her symptoms today and feels "fairly miserable".  She explained she is "prone to vertigo" because she has "benign positional vertigo". She asked if this experience was normal to the first dose of the vaccine and if the vaccine emphasizing her condition, the positional vertigo. Consumer stated that she should go on to the portal but to tell the truth she had such bad vertigo. She do not use very much and certainly not sit in the computer.  She was fine on Thursday and Friday and Saturday morning she have the worse, severe headache she have ever had, unbelievable vertigo and she have got an upset stomach. So basically, importantly it says that she have just had (incomplete sentence). Her immune system is 'driving' up to the vaccine but she certainly going to get the second shot because COVID gives her more than what she was going (Clarification unknown) through but is this a normal reaction. In response to further probing, consumer stated, she do not feel so well. She do not want to spend another 8 or 10 minutes in answering questions. Events were assessed as non-serious by reporter. Outcome of all events was unknown.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Vertigo
Clinical narrative: sore arm; Vestibular headache; nausea; real unsteady on her feet; Vertigo; Upset stomach; Do not feel so well; This is a spontaneous report from a contactable consumer (Patient).  A 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9264), via an unspecified route of administration on an unspecified date in 2021 as dose1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021, the patient experienced sore arm, vestibular headache, nausea, real unsteady on her feet, vertigo, upset stomach, do not feel so well. It was reported that patient after first dose on last Wednesday (in 2021) had She reported that beside a "minor sore arm", she "felt fine" on Thursday and Friday. She added she "didn't move off the couch" on Saturday because she had a "vestibular headache and nausea". She specified she was able to "move some" on Sunday but "wouldn't pick up" things on the floor, and felt "real unsteady on her feet". She mentioned she still has her symptoms today and feels "fairly miserable".  She explained she is "prone to vertigo" because she has "benign positional vertigo". She asked if this experience was normal to the first dose of the vaccine and if the vaccine emphasizing her condition, the positional vertigo. Consumer stated that she should go on to the portal but to tell the truth she had such bad vertigo. She do not use very much and certainly not sit in the computer.  She was fine on Thursday and Friday and Saturday morning she have the worse, severe headache she have ever had, unbelievable vertigo and she have got an upset stomach. So basically, importantly it says that she have just had (incomplete sentence). Her immune system is 'driving' up to the vaccine but she certainly going to get the second shot because COVID gives her more than what she was going (Clarification unknown) through but is this a normal reaction. In response to further probing, consumer stated, she do not feel so well. She do not want to spend another 8 or 10 minutes in answering questions. Events were assessed as non-serious by reporter. Outcome of all events was unknown.  Follow-up attempts completed. No further information expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash papular
Clinical narrative: prickly pimply rash; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A non-pregnant 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN9581 and Expiration date: not reported) via an unspecified route of administration, administered on the right arm on 16Feb2021 17:45 (at the age of 59 years old) as dose 1, single for COVID-19 immunisation. The vaccine was administered in a Public Health Clinic. The patient's medical history included high blood pressure, atrial flutter, shingles in 2015, Zika virus in 2016, and sulfa allergy. Concomitant medications included amlodipine besilate;benazepril hydrochloride (AMLODIPINE/BENAZEPRIL), metoprolol, and acetylsalicylic acid (BABY ASPIRIN) taken for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 23Feb2021 18:00, the patient started getting a prickly pimply rash on the lower back. Since then, it started spreading around the upper arms, legs, torso, and neck. On 27Feb2021, it was reported that the rash was pretty much everywhere. The patient also reported that she experienced a similar rash when she had the Zika virus and shingles. The patient used diphenhydramine hydrochloride (BENADRYL) as treatment but reported that the rash seemed to be getting worse than better. The outcome of the reported event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: prickly pimply rash; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A non-pregnant 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN9581 and Expiration date: not reported) via an unspecified route of administration, administered on the right arm on 16Feb2021 17:45 (at the age of 59 years old) as dose 1, single for COVID-19 immunisation. The vaccine was administered in a Public Health Clinic. The patient's medical history included high blood pressure, atrial flutter, shingles in 2015, Zika virus in 2016, and sulfa allergy. Concomitant medications included amlodipine besilate;benazepril hydrochloride (AMLODIPINE/BENAZEPRIL), metoprolol, and acetylsalicylic acid (BABY ASPIRIN) taken for unspecified indications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. On 23Feb2021 18:00, the patient started getting a prickly pimply rash on the lower back. Since then, it started spreading around the upper arms, legs, torso, and neck. On 27Feb2021, it was reported that the rash was pretty much everywhere. The patient also reported that she experienced a similar rash when she had the Zika virus and shingles. The patient used diphenhydramine hydrochloride (BENADRYL) as treatment but reported that the rash seemed to be getting worse than better. The outcome of the reported event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Electrocardiogram
Clinical narrative: chest pain rating pain 7/10; This is a spontaneous report from a contactable Nurse. A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN6203), dose 2 intramuscular, administered in Arm Right on 01Mar2021 at 12:15 (at the age of 78-years-old) as DOSE 2, SINGLE for covid-19 immunisation at clinic. The patient medical history included, hypertension, hyperlipidaemia, diabetes mellitus and depression from an unknown date and unknown if ongoing Other medical history. Concomitant medications in two weeks included lisinopril (LISINOPRIL), buspirone (BUSPIRONE), furosemide (FUROSEMIDE), trazodone (TRAZODONE), asa (ASA), metformin (METFORMIN) all were taken for an unspecified indication, start and stop date were not reported. The patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported), dose 1 intramuscular, administered in Arm Left on 24Jan2021 at 01:30 PM (at the age of 78-years-old) as a DOSE 1, SINGLE for covid-19 immunisation. The patient had no known allergies. It is unknown if patient had other vaccine in four weeks. Patient did not have covid prior vaccination and it was unknown if tested for covid post vaccination. The patient experienced chest pain rating pain 7/10 on 01Mar2021 at 12:30. It was reported that, within 10mins of second dose patient reported new onset chest pain rating pain 7/10, vital signs obtained, EMS called, EKG obtained, dose of ASA given, and patient transported to ER for further evaluation. Therapeutic measures were taken as a result of chest pain rating pain 7/10 (chest pain). Events resulted in the Emergency room/department or urgent care. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain
Clinical narrative: chest pain rating pain 7/10; This is a spontaneous report from a contactable Nurse. A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: EN6203), dose 2 intramuscular, administered in Arm Right on 01Mar2021 at 12:15 (at the age of 78-years-old) as DOSE 2, SINGLE for covid-19 immunisation at clinic. The patient medical history included, hypertension, hyperlipidaemia, diabetes mellitus and depression from an unknown date and unknown if ongoing Other medical history. Concomitant medications in two weeks included lisinopril (LISINOPRIL), buspirone (BUSPIRONE), furosemide (FUROSEMIDE), trazodone (TRAZODONE), asa (ASA), metformin (METFORMIN) all were taken for an unspecified indication, start and stop date were not reported. The patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported), dose 1 intramuscular, administered in Arm Left on 24Jan2021 at 01:30 PM (at the age of 78-years-old) as a DOSE 1, SINGLE for covid-19 immunisation. The patient had no known allergies. It is unknown if patient had other vaccine in four weeks. Patient did not have covid prior vaccination and it was unknown if tested for covid post vaccination. The patient experienced chest pain rating pain 7/10 on 01Mar2021 at 12:30. It was reported that, within 10mins of second dose patient reported new onset chest pain rating pain 7/10, vital signs obtained, EMS called, EKG obtained, dose of ASA given, and patient transported to ER for further evaluation. Therapeutic measures were taken as a result of chest pain rating pain 7/10 (chest pain). Events resulted in the Emergency room/department or urgent care. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Gout, Hyperhidrosis, Pruritus, Rash
Clinical narrative: An attack of gout; Chills; Hives; Rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest; Rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest; absolutely soaked in the gown patient was wearing. patient had never sweat like that; Joint pain; Lost a lot of sleep because of itching; Lost a lot of sleep because of itching / itching; Knuckles were all red and it hurt to move her hands; This is a spontaneous report from a contactable consumer (reported for herself). This female patient of age 87 units unspecified received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EM9809), via an unspecified route of administration on 21Feb2021 16:00 (age at the vaccination was 87 units unspecified) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 21Fbe2021 20:00, the patient stated that "nothing happening sooner", lots of reaction and the patient was up all night which consisted of hives, itching, rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest, sweats, joint pain that turned into "an attack of gout." Patient states that her knuckles were all red and it hurt to move her hands, she lost a lot of sleep because of itching, chills. Patient absolutely soaked in the gown patient was wearing. Patient had never sweat like that previously. Patient reports that she had no injection site pain and she "can do anything with that arm. It's as if there wasn't a shot there." Patient stated that she took 2 grams of prednisone/cortisone last night without the advice of a doctor for the events hives, prickly heat rash and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest and itching. Patient asked was this normal. Something that happened. The patient asked my symptoms ever get reported. Patient stated that she went to the doctor on an unknown dated as the patient took 2 doses of the prednisone, there was no rash to show them, and the hives were gone. The outcome of the events an attack of gout, chills, absolutely soaked in the gown patient was wearing. patient had never sweat like that, joint pain, lost a lot of sleep because of itching, knuckles were all red and it hurt to move her hands was unknown. The outcome of the events hives, rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest, lost a lot of sleep because of itching / itching was resolved on an unknown date 2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous, Urticaria
Clinical narrative: An attack of gout; Chills; Hives; Rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest; Rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest; absolutely soaked in the gown patient was wearing. patient had never sweat like that; Joint pain; Lost a lot of sleep because of itching; Lost a lot of sleep because of itching / itching; Knuckles were all red and it hurt to move her hands; This is a spontaneous report from a contactable consumer (reported for herself). This female patient of age 87 units unspecified received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EM9809), via an unspecified route of administration on 21Feb2021 16:00 (age at the vaccination was 87 units unspecified) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 21Fbe2021 20:00, the patient stated that "nothing happening sooner", lots of reaction and the patient was up all night which consisted of hives, itching, rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest, sweats, joint pain that turned into "an attack of gout." Patient states that her knuckles were all red and it hurt to move her hands, she lost a lot of sleep because of itching, chills. Patient absolutely soaked in the gown patient was wearing. Patient had never sweat like that previously. Patient reports that she had no injection site pain and she "can do anything with that arm. It's as if there wasn't a shot there." Patient stated that she took 2 grams of prednisone/cortisone last night without the advice of a doctor for the events hives, prickly heat rash and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest and itching. Patient asked was this normal. Something that happened. The patient asked my symptoms ever get reported. Patient stated that she went to the doctor on an unknown dated as the patient took 2 doses of the prednisone, there was no rash to show them, and the hives were gone. The outcome of the events an attack of gout, chills, absolutely soaked in the gown patient was wearing. patient had never sweat like that, joint pain, lost a lot of sleep because of itching, knuckles were all red and it hurt to move her hands was unknown. The outcome of the events hives, rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest, lost a lot of sleep because of itching / itching was resolved on an unknown date 2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Erythema, Gout, Hyperhidrosis
Clinical narrative: An attack of gout; Chills; Hives; Rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest; Rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest; absolutely soaked in the gown patient was wearing. patient had never sweat like that; Joint pain; Lost a lot of sleep because of itching; Lost a lot of sleep because of itching / itching; Knuckles were all red and it hurt to move her hands; This is a spontaneous report from a contactable consumer (reported for herself). This female patient of age 87 units unspecified received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EM9809), via an unspecified route of administration on 21Feb2021 16:00 (age at the vaccination was 87 units unspecified) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 21Fbe2021 20:00, the patient stated that "nothing happening sooner", lots of reaction and the patient was up all night which consisted of hives, itching, rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest, sweats, joint pain that turned into "an attack of gout." Patient states that her knuckles were all red and it hurt to move her hands, she lost a lot of sleep because of itching, chills. Patient absolutely soaked in the gown patient was wearing. Patient had never sweat like that previously. Patient reports that she had no injection site pain and she "can do anything with that arm. It's as if there wasn't a shot there." Patient stated that she took 2 grams of prednisone/cortisone last night without the advice of a doctor for the events hives, prickly heat rash and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest and itching. Patient asked was this normal. Something that happened. The patient asked my symptoms ever get reported. Patient stated that she went to the doctor on an unknown dated as the patient took 2 doses of the prednisone, there was no rash to show them, and the hives were gone. The outcome of the events an attack of gout, chills, absolutely soaked in the gown patient was wearing. patient had never sweat like that, joint pain, lost a lot of sleep because of itching, knuckles were all red and it hurt to move her hands was unknown. The outcome of the events hives, rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest, lost a lot of sleep because of itching / itching was resolved on an unknown date 2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Insomnia, Limb injury, Miliaria, Pruritus, Urticaria
Clinical narrative: An attack of gout; Chills; Hives; Rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest; Rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest; absolutely soaked in the gown patient was wearing. patient had never sweat like that; Joint pain; Lost a lot of sleep because of itching; Lost a lot of sleep because of itching / itching; Knuckles were all red and it hurt to move her hands; This is a spontaneous report from a contactable consumer (reported for herself). This female patient of age 87 units unspecified received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EM9809), via an unspecified route of administration on 21Feb2021 16:00 (age at the vaccination was 87 units unspecified) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 21Fbe2021 20:00, the patient stated that "nothing happening sooner", lots of reaction and the patient was up all night which consisted of hives, itching, rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest, sweats, joint pain that turned into "an attack of gout." Patient states that her knuckles were all red and it hurt to move her hands, she lost a lot of sleep because of itching, chills. Patient absolutely soaked in the gown patient was wearing. Patient had never sweat like that previously. Patient reports that she had no injection site pain and she "can do anything with that arm. It's as if there wasn't a shot there." Patient stated that she took 2 grams of prednisone/cortisone last night without the advice of a doctor for the events hives, prickly heat rash and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest and itching. Patient asked was this normal. Something that happened. The patient asked my symptoms ever get reported. Patient stated that she went to the doctor on an unknown dated as the patient took 2 doses of the prednisone, there was no rash to show them, and the hives were gone. The outcome of the events an attack of gout, chills, absolutely soaked in the gown patient was wearing. patient had never sweat like that, joint pain, lost a lot of sleep because of itching, knuckles were all red and it hurt to move her hands was unknown. The outcome of the events hives, rash described as prickly heat and red that appeared on the inside of her thighs, underside of arms, around breasts, and on chest, lost a lot of sleep because of itching / itching was resolved on an unknown date 2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: chills; fatigue; headache; This is a spontaneous report from a contactable other healthcare professional Nurse (patient). A female patient of age 66 (units not provided) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EM9809), via an unspecified route of administration on 08Feb2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The caller stated she received the first dose of the vaccine late afternoon on 08Feb2021 and reported she had a reaction. She felt absolutely fine until 11Feb2021 when she went to bed and got chills. She never got a fever. On 12Feb2021 she had a bad headache and fatigue. She said the reaction was delayed and she felt fine for a couple days. She stated she woke up in the night between Thursday and Friday with chills but no fever. On Friday (12Feb2021) she had a headache, but it was manageable with Tylenol but then she had fatigue. She stated it all went away Saturday when she woke up like nothing happened, except for the intermittent headache that she managed with Tylenol. She said the headache was moderate and did not keep her down. She stated she had no respiratory issues. The caller asked if this was a reported reaction and if this may occur with the second dose. She heard the second dose had more symptoms. She was scheduled for the second dose on 01Mar2021. The patient took Tylenol for headache. All of the events subsided except the headache which was intermittent through the weekend but not bad. She could take Tylenol and it will go away. She wanted to make sure that these events are normal with the Pfizer COVID-19 Vaccine, as they started towards the very end of the anticipated timeline of side effect onset. She works as an HR Nurse and wanted to make sure it was ok to return to work. The outcome of all events was recovered except headache which was recovering.  Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Tremor
Clinical narrative: shaking for about 5 minutes; This is a spontaneous report from two contactable consumer. This consumer (daughter) and a (Age: 82, Unit: unknown) female consumer (patient) reported that a female patient of an unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/ lot number: unknown), via an unknown route of administration on 16Jan2021 as single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in 2021, the patient experienced shaking for about 5 minutes. After the first dose only, symptom was shaking for about 5 minutes. The 2nd dose was given on 06Feb2021 and got headache, pain and joint pain, fatigue, elevated fever lasted for about 48 hours. She was in bed lethargic. Also reported that, this week's concern was her blood glucose level has spiked the entire week. The blood sugar was normal for the day, but went up and down, spiking and up and down. The patient underwent lab tests and procedures which included blood glucose: spiked on unknown date. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose, Tremor
Clinical narrative: shaking for about 5 minutes; This is a spontaneous report from two contactable consumer. This consumer (daughter) and a (Age: 82, Unit: unknown) female consumer (patient) reported that a female patient of an unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/ lot number: unknown), via an unknown route of administration on 16Jan2021 as single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date in 2021, the patient experienced shaking for about 5 minutes. After the first dose only, symptom was shaking for about 5 minutes. The 2nd dose was given on 06Feb2021 and got headache, pain and joint pain, fatigue, elevated fever lasted for about 48 hours. She was in bed lethargic. Also reported that, this week's concern was her blood glucose level has spiked the entire week. The blood sugar was normal for the day, but went up and down, spiking and up and down. The patient underwent lab tests and procedures which included blood glucose: spiked on unknown date. The outcome of the event was unknown.   Follow-up attempts are completed. No further information is expected.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Fatigue, Injection site pain
Clinical narrative: EXPLOSIVE DIARREA, liquid , I can not hold it; This is a spontaneous report from a contactable consumer, the patient. A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, administered on 09Feb2021 as dose 2, single for covid-19 immunization. The patient medical history included gastrobypass in 2004 and secondary stetoterra diarrea. The patient concomitant medications were not reported. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not reported) via an unspecified route of administration as dose 1, single for covid-19 immunisation and experienced small sore in the site for at day, after one day the pm the patient was very fatigue. On an unspecified date in Feb2021, the patient had experienced explosive diarrea, liquid, and could not hold it. The outcome of event was unknown on an unspecified date.  Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Diarrhoea
Clinical narrative: EXPLOSIVE DIARREA, liquid , I can not hold it; This is a spontaneous report from a contactable consumer, the patient. A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, administered on 09Feb2021 as dose 2, single for covid-19 immunization. The patient medical history included gastrobypass in 2004 and secondary stetoterra diarrea. The patient concomitant medications were not reported. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not reported) via an unspecified route of administration as dose 1, single for covid-19 immunisation and experienced small sore in the site for at day, after one day the pm the patient was very fatigue. On an unspecified date in Feb2021, the patient had experienced explosive diarrea, liquid, and could not hold it. The outcome of event was unknown on an unspecified date.  Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anal incontinence, Diarrhoea
Clinical narrative: EXPLOSIVE DIARREA, liquid , I can not hold it; This is a spontaneous report from a contactable consumer, the patient. A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, administered on 09Feb2021 as dose 2, single for covid-19 immunization. The patient medical history included gastrobypass in 2004 and secondary stetoterra diarrea. The patient concomitant medications were not reported. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not reported) via an unspecified route of administration as dose 1, single for covid-19 immunisation and experienced small sore in the site for at day, after one day the pm the patient was very fatigue. On an unspecified date in Feb2021, the patient had experienced explosive diarrea, liquid, and could not hold it. The outcome of event was unknown on an unspecified date.  Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: EXPLOSIVE DIARREA, liquid , I can not hold it; This is a spontaneous report from a contactable consumer, the patient. A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, administered on 09Feb2021 as dose 2, single for covid-19 immunization. The patient medical history included gastrobypass in 2004 and secondary stetoterra diarrea. The patient concomitant medications were not reported. The patient had previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not reported) via an unspecified route of administration as dose 1, single for covid-19 immunisation and experienced small sore in the site for at day, after one day the pm the patient was very fatigue. On an unspecified date in Feb2021, the patient had experienced explosive diarrea, liquid, and could not hold it. The outcome of event was unknown on an unspecified date.  Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Diarrhoea, Fatigue, Injection site pain
Clinical narrative: fine small sore in the site for at day; after one day the pm I was very fatigue; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. Medical history included gastrobypass in 2004, after which patient had to be and taken care of not grease in food because patient got secondary stetoterra, diarrhea. Concomitant medications were not reported. After the first vaccine, on an unspecified date patient experienced fine small sore in the site for at day, after one day the pm patient was very fatigue. The outcome of the events was unknown.   Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Diarrhoea
Clinical narrative: fine small sore in the site for at day; after one day the pm I was very fatigue; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. Medical history included gastrobypass in 2004, after which patient had to be and taken care of not grease in food because patient got secondary stetoterra, diarrhea. Concomitant medications were not reported. After the first vaccine, on an unspecified date patient experienced fine small sore in the site for at day, after one day the pm patient was very fatigue. The outcome of the events was unknown.   Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Anal incontinence, Diarrhoea
Clinical narrative: fine small sore in the site for at day; after one day the pm I was very fatigue; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. Medical history included gastrobypass in 2004, after which patient had to be and taken care of not grease in food because patient got secondary stetoterra, diarrhea. Concomitant medications were not reported. After the first vaccine, on an unspecified date patient experienced fine small sore in the site for at day, after one day the pm patient was very fatigue. The outcome of the events was unknown.   Follow-up attempts completed. No further information expected.
Sex: U
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: fine small sore in the site for at day; after one day the pm I was very fatigue; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: unknown, expiry date: unknown) via unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. Medical history included gastrobypass in 2004, after which patient had to be and taken care of not grease in food because patient got secondary stetoterra, diarrhea. Concomitant medications were not reported. After the first vaccine, on an unspecified date patient experienced fine small sore in the site for at day, after one day the pm patient was very fatigue. The outcome of the events was unknown.   Follow-up attempts completed. No further information expected.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling abnormal
Clinical narrative: dizziness; Orthostatic hypotension; This is a spontaneous report from a contactable Nurse (Patient). A 66-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number N6201) via an unspecified route of administration, administered in arm left on 14Feb2021 17:00 (age at vaccination 66 years) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced dizziness and orthostatic hypotension both on 15Feb2021 06:15. It was reported as patient received the Pfizer vaccine yesterday 14Feb2021 and experienced dizziness and stated that dizziness was listed as a severe reaction to the covid 19 vaccine and wanted to know if there have been any reports of dizziness. Patient felt kind like orthostatic hypotension. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.